Načítá se...
Immunosuppression in inflammatory bowel disease: how much is too much?
PURPOSE OF REVIEW: Current treatment approaches favor the early introduction of immunomodulators and/or antitumor necrosis factor (TNF) agents. There is now strong evidence showing that combination therapy appears to be more effective than monotherapy in both ulcerative colitis and Crohn’s disease....
Uloženo v:
| Vydáno v: | Curr Opin Gastroenterol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6681654/ https://ncbi.nlm.nih.gov/pubmed/22573191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MOG.0b013e328354567f |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|